Safety and Efficacy of Anti-TL1A Monoclonal Antibodies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Background & Objective: Tumor necrosis factor-like ligand 1A (TL1A) has been associated with mucosal inflammation, fibrosis, and epithelial barrier dysfunction in inflammatory bowel disease (IBD). Monoclonal antibodies against TL1A have emerged as potential therapies for moderate-to-severe ulcerative colitis (UC) and C...